Error: Could not add to watchlist. X
+ Watchlist

InSite Vision Inc

INSV:US
Acquired
INSV:US was acquired by SUNP:IN
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.100
Market Cap (USD)
-
Shares Outstanding (m)
131.951
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.21%
% Price Change
-0.28%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
InSite Vision Incorporated develops ophthalmic pharmaceutical products based on its DuraSite drug delivery technology. The Company also develops genetically based tools for the diagnosis and prognosis of glaucoma. InSite's products are intended to address a broad spectrum of ocular indications, including glaucoma, inflammation, and infection.
Address
965 Atlantic Avenue
Alameda, CA 94501
United States
Phone
1-510-865-8800
Show More